Nuvation Bio Inc.
NUVB
$4.32
-$0.40-8.48%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 98.80% | 219.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 98.80% | 219.09% | |||
| Cost of Revenue | 368.41% | -61.81% | |||
| Gross Profit | 90.30% | 315.37% | |||
| SG&A Expenses | -5.00% | 7.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.54% | 9.13% | |||
| Operating Income | 111.40% | 39.69% | |||
| Income Before Tax | 114.75% | 34.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 114.75% | 34.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 114.75% | 34.41% | |||
| EBIT | 111.40% | 39.69% | |||
| EBITDA | 113.19% | 40.08% | |||
| EPS Basic | 114.58% | 34.75% | |||
| Normalized Basic EPS | 114.61% | 34.77% | |||
| EPS Diluted | 114.58% | 34.75% | |||
| Normalized Diluted EPS | 114.61% | 34.77% | |||
| Average Basic Shares Outstanding | 0.87% | 0.57% | |||
| Average Diluted Shares Outstanding | 0.87% | 0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||